The National Cancer Institute’s “cancer moonshot” tasks researchers with, among advancing other new biotechnologies, delving into immunotherapy and epigenomic analysis.
The depth and breadth of post-diagnosis care for cancer patients often depends on the resources available to them.
Researchers at UC Merced are playing key roles in the new UC Valley Fever Research Initiative, studying